{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:11:19Z","timestamp":1793304679041,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.survophthal.2005.07.001","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T07:22:43Z","timestamp":1130484163000},"page":"S32-S45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"S","title":["Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans"],"prefix":"10.1016","volume":"50","author":[{"given":"Stella M.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Schlech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rusinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey R.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Dembinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Dahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2005.07.001_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.ico.0000134462.88535.d0","article-title":"Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits","volume":"24","author":"Aliprandis","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2005.07.001_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/eye.1999.137","article-title":"Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration","volume":"13","author":"Cekic","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2005.07.001_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006982-199806000-00005","article-title":"Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration","volume":"18","author":"Cekic","year":"1998","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2005.07.001_bib4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0161-6420(13)31248-2","article-title":"Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor","volume":"101","author":"Donnenfeld","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.07.001_bib5","first-page":"532","article-title":"In vitro topically applied fluoroquinolone penetration into the anterior chamber","volume":"99","author":"Fukada","year":"1995","journal-title":"Nippon Ganka Gakkai Sasshi"},{"key":"10.1016\/j.survophthal.2005.07.001_bib6","series-title":"Principles and Practices of Ophthalmology","article-title":"Anatomy and cell biology of the cornea, superficial limbus and conjunctiva","author":"Gipson","year":"2000"},{"key":"10.1016\/j.survophthal.2005.07.001_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archopht.123.1.39","article-title":"Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous","volume":"123","author":"Hariprasad","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.07.001_bib8","unstructured":"Katz HR, Masket S, Lane SS, et al: Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea (in press)"},{"key":"10.1016\/j.survophthal.2005.07.001_bib9","unstructured":"Kim DH, Stark WJ, O'Brien TP, Dick JD:Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients Ophthalmology. In press."},{"key":"10.1016\/j.survophthal.2005.07.001_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.07.001_bib11","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jcrs.2004.06.048","article-title":"Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing","volume":"30","author":"Levine","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2005.07.001_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ajo.2004.05.011","article-title":"The effect of cataract surgery on ocular levels of topical moxifloxacin","volume":"138","author":"Mather","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.07.001_bib13","doi-asserted-by":"crossref","unstructured":"Price MO, Quillin C, Price FW: Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration. Cur Eye Res 30:563\u20137, 2005.","DOI":"10.1080\/02713680590968556"},{"key":"10.1016\/j.survophthal.2005.07.001_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ophtha.2004.09.029","article-title":"Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor","volume":"112","author":"Solomon","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2005.07.001_bib15","doi-asserted-by":"crossref","unstructured":"Wagner RS, Abelson MB, Shapiro A, Torkildsen G: Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Opthalmol 123:1282\u20133, 2005","DOI":"10.1001\/archopht.123.9.1282"},{"key":"10.1016\/j.survophthal.2005.07.001_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1076\/ceyr.24.5.403.8517","article-title":"Aqueous humor levels of topically applied levofloxacin in human eyes","volume":"24","author":"Yamada","year":"2002","journal-title":"Curr Eye Res"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625705000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625705000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:28:58Z","timestamp":1758540538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625705000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0039625705000925"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2005.07.001","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2005.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}